Compare CCOI & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCOI | TNDM |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | CCOI | TNDM |
|---|---|---|
| Price | $22.44 | $23.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 16 |
| Target Price | ★ $30.25 | $24.00 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 18.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $907,233,000.00 | ★ $1,007,001,000.00 |
| Revenue This Year | $4.54 | $8.59 |
| Revenue Next Year | $2.69 | $10.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.87 |
| 52 Week Low | $15.96 | $9.98 |
| 52 Week High | $84.06 | $38.28 |
| Indicator | CCOI | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 70.72 |
| Support Level | $21.69 | $21.75 |
| Resistance Level | $24.08 | $24.50 |
| Average True Range (ATR) | 1.43 | 1.20 |
| MACD | 0.73 | 0.03 |
| Stochastic Oscillator | 52.43 | 86.18 |
Cogent carries over one-fifth of the world's internet traffic on its network, providing high-capacity services to businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.